Investor Relations 2019-01-31T09:03:23-07:00

Investor Relations

Marrone Bio Innovations, Inc. (NASDAQ: MBII) strives to lead the movement to more sustainable world through the discovery, development and sale of innovative biological products for crop protection, plant health and waterway systems treatment. MBI has screened over 18,000 microorganisms and 350 plant extracts, leveraging its in-depth knowledge of plant and soil microbiomes enhanced by advanced molecular technologies to rapidly develop seven effective and environmentally responsible pest management products to help customers operate more sustainably while uniquely improving plant health, increasing crop yields and achieving a better return on investment. Supported by a robust portfolio of over 400 issued and pending patents around its superior natural product chemistry, MBI’s currently available commercial products are Regalia®, Grandevo®, Venerate®, Majestene®, Haven®, Stargus®, Amplitude™, Zelto® and Zequanox®.

Marrone Bio Innovations, Inc.
Pamela Marrone, Ph.D. – Founder and CEO

Settlement of Shareholder Derivative Lawsuits

Stipulation of Settlement
Notice of Pendency of Proposed Settlement of Stockholder Derivative Action

Subscribe to Marrone Bio Innovations Email Alerts

Please fill out the form below to receive company press releases and relevant media items via email when they occur.